Cargando…
Severe COVID-19 as a Possible Mediator of Autoimmunity and Sjögren’s Syndrome
We treated a 65-year-old man for COVID-19 who was hospitalized urgently due to life-threatening respiratory decompensation and later developed cardiac arrest, both of which were successfully treated. Three days prior to the patient's urgent hospitalization, he had a high fever of over 38.0°C. V...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039762/ https://www.ncbi.nlm.nih.gov/pubmed/36974237 http://dx.doi.org/10.7759/cureus.35290 |
_version_ | 1784912336944889856 |
---|---|
author | Konishi, Kazuhisa Kuwahara, Hiroomi Fujimoto, Yasuko Nagata, Kazuhiro Takeda, Jun |
author_facet | Konishi, Kazuhisa Kuwahara, Hiroomi Fujimoto, Yasuko Nagata, Kazuhiro Takeda, Jun |
author_sort | Konishi, Kazuhisa |
collection | PubMed |
description | We treated a 65-year-old man for COVID-19 who was hospitalized urgently due to life-threatening respiratory decompensation and later developed cardiac arrest, both of which were successfully treated. Three days prior to the patient's urgent hospitalization, he had a high fever of over 38.0°C. Viral infection was diagnosed by polymerase chain reaction (PCR) on the day of admission, which was negative on the 11th day. Blood analysis on the second day was strongly positive for COVID-19 IgG antibodies, which continued for one year. Because of the acute increase in viral IgG antibodies, we performed other immunological analyses; Sjögren's syndrome antigen A (SS-A) and Sjögren's syndrome antigen B (SS-B) antibodies were positive, although he had no history of autoimmune diseases. Subsequent salivary-gland biopsy and pathological analysis confirmed the diagnosis of Sjögren’s syndrome. The severe clinical manifestations and early antibody seroconversion in this case suggest COVID-19 as a mediator of autoimmunity and Sjögren’s syndrome. |
format | Online Article Text |
id | pubmed-10039762 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-100397622023-03-26 Severe COVID-19 as a Possible Mediator of Autoimmunity and Sjögren’s Syndrome Konishi, Kazuhisa Kuwahara, Hiroomi Fujimoto, Yasuko Nagata, Kazuhiro Takeda, Jun Cureus Emergency Medicine We treated a 65-year-old man for COVID-19 who was hospitalized urgently due to life-threatening respiratory decompensation and later developed cardiac arrest, both of which were successfully treated. Three days prior to the patient's urgent hospitalization, he had a high fever of over 38.0°C. Viral infection was diagnosed by polymerase chain reaction (PCR) on the day of admission, which was negative on the 11th day. Blood analysis on the second day was strongly positive for COVID-19 IgG antibodies, which continued for one year. Because of the acute increase in viral IgG antibodies, we performed other immunological analyses; Sjögren's syndrome antigen A (SS-A) and Sjögren's syndrome antigen B (SS-B) antibodies were positive, although he had no history of autoimmune diseases. Subsequent salivary-gland biopsy and pathological analysis confirmed the diagnosis of Sjögren’s syndrome. The severe clinical manifestations and early antibody seroconversion in this case suggest COVID-19 as a mediator of autoimmunity and Sjögren’s syndrome. Cureus 2023-02-22 /pmc/articles/PMC10039762/ /pubmed/36974237 http://dx.doi.org/10.7759/cureus.35290 Text en Copyright © 2023, Konishi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Emergency Medicine Konishi, Kazuhisa Kuwahara, Hiroomi Fujimoto, Yasuko Nagata, Kazuhiro Takeda, Jun Severe COVID-19 as a Possible Mediator of Autoimmunity and Sjögren’s Syndrome |
title | Severe COVID-19 as a Possible Mediator of Autoimmunity and Sjögren’s Syndrome |
title_full | Severe COVID-19 as a Possible Mediator of Autoimmunity and Sjögren’s Syndrome |
title_fullStr | Severe COVID-19 as a Possible Mediator of Autoimmunity and Sjögren’s Syndrome |
title_full_unstemmed | Severe COVID-19 as a Possible Mediator of Autoimmunity and Sjögren’s Syndrome |
title_short | Severe COVID-19 as a Possible Mediator of Autoimmunity and Sjögren’s Syndrome |
title_sort | severe covid-19 as a possible mediator of autoimmunity and sjögren’s syndrome |
topic | Emergency Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039762/ https://www.ncbi.nlm.nih.gov/pubmed/36974237 http://dx.doi.org/10.7759/cureus.35290 |
work_keys_str_mv | AT konishikazuhisa severecovid19asapossiblemediatorofautoimmunityandsjogrenssyndrome AT kuwaharahiroomi severecovid19asapossiblemediatorofautoimmunityandsjogrenssyndrome AT fujimotoyasuko severecovid19asapossiblemediatorofautoimmunityandsjogrenssyndrome AT nagatakazuhiro severecovid19asapossiblemediatorofautoimmunityandsjogrenssyndrome AT takedajun severecovid19asapossiblemediatorofautoimmunityandsjogrenssyndrome |